Class information for:
Level 1: OPC 21268//YM087//VASOPRESSIN RECEPTOR ANTAGONIST

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
6585 1467 31.2 60%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
127 3       OXYTOCIN//BEHAVIORAL SCIENCES//VASOPRESSIN 67291
276 2             OXYTOCIN//VASOPRESSIN//HYPONATREMIA 19172
6585 1                   OPC 21268//YM087//VASOPRESSIN RECEPTOR ANTAGONIST 1467

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OPC 21268 authKW 250615 1% 71% 17
2 YM087 authKW 209864 1% 92% 11
3 VASOPRESSIN RECEPTOR ANTAGONIST authKW 150793 2% 32% 23
4 ARGININE VASOPRESSIN ANTAGONIST authKW 148003 1% 89% 8
5 SR 49059 authKW 139902 1% 61% 11
6 VASOPRESSIN ANTAGONIST authKW 135246 2% 25% 26
7 TOLVAPTAN authKW 132803 2% 21% 30
8 VASOPRESSIN authKW 131349 12% 4% 172
9 VASOPRESSIN V 1A RECEPTOR authKW 109533 1% 53% 10
10 OPC 31260 authKW 94594 1% 45% 10

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Physiology 8341 26% 0% 386
2 Peripheral Vascular Diseases 3645 15% 0% 222
3 Pharmacology & Pharmacy 3190 29% 0% 419
4 Cardiac & Cardiovascular System 1756 15% 0% 214
5 Endocrinology & Metabolism 487 8% 0% 120
6 Medicine, Research & Experimental 432 7% 0% 110
7 Chemistry, Medicinal 185 4% 0% 60
8 Urology & Nephrology 177 4% 0% 58
9 Neurosciences 62 7% 0% 96
10 Medicine, General & Internal 20 4% 0% 52

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 BIOQIM 20813 0% 100% 1
2 CARDIOVASC TRAINING MED 20813 0% 100% 1
3 CLIN DEV ADM 20813 0% 100% 1
4 CORP PLANNING CHUO KU 20813 0% 100% 1
5 DRUG DISVOVERY 20813 0% 100% 1
6 EA 2035 20813 0% 100% 1
7 EMI 0015 INSERM 20813 0% 100% 1
8 GYULA TEACHER TRAINING 20813 0% 100% 1
9 HOSP CLIN UNIVHORMONAL 20813 0% 100% 1
10 HOSP CLIN UNIVLIVER UNIT 20813 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMERICAN JOURNAL OF PHYSIOLOGY 26377 12% 1% 177
2 CLINICAL AND EXPERIMENTAL HYPERTENSION PART A-THEORY AND PRACTICE 10234 2% 2% 26
3 HYPERTENSION 9852 5% 1% 74
4 JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 6740 4% 1% 60
5 CLINICAL SCIENCE 6155 3% 1% 44
6 JOURNAL OF HYPERTENSION 4900 3% 0% 48
7 PHYSIOLOGIA BOHEMOSLOVACA 1484 0% 1% 7
8 JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM 1482 1% 1% 13
9 FEDERATION PROCEEDINGS 1364 1% 1% 10
10 AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY 1341 2% 0% 24

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 OPC 21268 250615 1% 71% 17 Search OPC+21268 Search OPC+21268
2 YM087 209864 1% 92% 11 Search YM087 Search YM087
3 VASOPRESSIN RECEPTOR ANTAGONIST 150793 2% 32% 23 Search VASOPRESSIN+RECEPTOR+ANTAGONIST Search VASOPRESSIN+RECEPTOR+ANTAGONIST
4 ARGININE VASOPRESSIN ANTAGONIST 148003 1% 89% 8 Search ARGININE+VASOPRESSIN+ANTAGONIST Search ARGININE+VASOPRESSIN+ANTAGONIST
5 SR 49059 139902 1% 61% 11 Search SR+49059 Search SR+49059
6 VASOPRESSIN ANTAGONIST 135246 2% 25% 26 Search VASOPRESSIN+ANTAGONIST Search VASOPRESSIN+ANTAGONIST
7 TOLVAPTAN 132803 2% 21% 30 Search TOLVAPTAN Search TOLVAPTAN
8 VASOPRESSIN 131349 12% 4% 172 Search VASOPRESSIN Search VASOPRESSIN
9 VASOPRESSIN V 1A RECEPTOR 109533 1% 53% 10 Search VASOPRESSIN+V+1A+RECEPTOR Search VASOPRESSIN+V+1A+RECEPTOR
10 OPC 31260 94594 1% 45% 10 Search OPC+31260 Search OPC+31260

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 SHARE, L , (1988) ROLE OF VASOPRESSIN IN CARDIOVASCULAR REGULATION.PHYSIOLOGICAL REVIEWS. VOL. 68. ISSUE 4. P. 1248-1284 88 61% 219
2 LASZLO, FA , LASZLO, F , DEWIED, D , (1991) PHARMACOLOGY AND CLINICAL PERSPECTIVES OF VASOPRESSIN ANTAGONISTS.PHARMACOLOGICAL REVIEWS. VOL. 43. ISSUE 1. P. 73-108 97 40% 192
3 VEERAVEEDU, PT , PALANIYANDI, SS , YAMAGUCHI, K , KOMAI, Y , THANDAVARAYAN, RA , SUKUMARAN, V , WATANABE, K , (2010) ARGININE VASOPRESSIN RECEPTOR ANTAGONISTS (VAPTANS): PHARMACOLOGICAL TOOLS AND POTENTIAL THERAPEUTIC AGENTS.DRUG DISCOVERY TODAY. VOL. 15. ISSUE 19-20. P. 826-841 56 46% 12
4 BURRELL, LM , RISVANIS, J , JOHNSTON, CI , NAITOH, M , BALDING, LC , (2000) VASOPRESSIN RECEPTOR ANTAGONISM - A THERAPEUTIC OPTION IN HEART FAILURE AND HYPERTENSION.EXPERIMENTAL PHYSIOLOGY. VOL. 85. ISSUE . P. 259S -265S 39 75% 26
5 LEE, CR , WATKINS, ML , PATTERSON, JH , GATTIS, W , O'CONNOR, CM , GHEORGHIADE, M , ADAMS, KF , (2003) VASOPRESSIN: A NEW TARGET FOR THE TREATMENT OF HEART FAILURE.AMERICAN HEART JOURNAL. VOL. 146. ISSUE 1. P. 9-18 31 76% 102
6 LEMMENS-GRUBER, R , KAMYAR, M , (2006) VASOPRESSIN ANTAGONISTS.CELLULAR AND MOLECULAR LIFE SCIENCES. VOL. 63. ISSUE 15. P. 1766-1779 50 45% 36
7 WONG, LL , VERBALIS, JG , (2001) VASOPRESSIN V2 RECEPTOR ANTAGONISTS.CARDIOVASCULAR RESEARCH. VOL. 51. ISSUE 3. P. 391 -402 41 62% 49
8 CROMBIE, AL , ANTRILLI, TM , CAMPBELL, BA , CRANDALL, DL , FAILLI, AA , HE, YN , KERN, JC , MOORE, WJ , NOGLE, LM , TRYBULSKI, EJ , (2010) SYNTHESIS AND EVALUATION OF AZABICYCLO[3.2.1]OCTANE DERIVATIVES AS POTENT MIXED VASOPRESSIN ANTAGONISTS.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 20. ISSUE 12. P. 3742-3745 21 95% 6
9 TAHARA, A , TSUKADA, J , TOMURA, Y , WADA, K , KUSAYAMA, T , ISHII, N , YATSU, T , UCHIDA, W , TANIGUCHI, N , TANAKA, A , (2002) EFFECT OF YM471, A NONPEPTIDE AVP RECEPTOR ANTAGONIST, ON HUMAN CORONARY ARTERY SMOOTH MUSCLE CELLS.PEPTIDES. VOL. 23. ISSUE 10. P. 1809-1816 35 69% 3
10 OGHLAKIAN, G , KLAPHOLZ, M , (2009) VASOPRESSIN AND VASOPRESSIN RECEPTOR ANTAGONISTS IN HEART FAILURE.CARDIOLOGY IN REVIEW. VOL. 17. ISSUE 1. P. 10 -15 36 51% 21

Classes with closest relation at Level 1


Rank Class id link
1 7294 OXYTOCIN RECEPTOR//OXYTOCIN ANTAGONIST//U469
2 14260 VASODILATORY SHOCK//VASOPLEGIA//TERLIPRESSIN
3 28371 PATHOPHYSIOL EXPT NEUROENDOCRINOL//NK 1 NK 2 RECEPTORS//BIOMED PHYSIOL MED BIOPHYS
4 21348 COPEPTIN//BRAHMS AKTIENGESELL//RULE OUT
5 6336 VASOPRESSIN//ARGININE8 VASOPRESSIN//AVP4 8
6 17977 CARDIAC RECEPTORS//ATRIAL RECEPTORS//QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY AND COGNATE MEDICAL SCIENCES
7 7919 AQUAPORIN 2//NEPHROGENIC DIABETES INSIPIDUS//KIDNEY ELE OLYTE METAB
8 1573 HYPONATREMIA//CENTRAL PONTINE MYELINOLYSIS//SIADH
9 857 SODIUM APPETITE//SUBFORNICAL ORGAN//THIRST
10 8205 CAROTID SINUS BAROREFLEX//CARDIOVASC DYNAM//ENVIRONM HLTH LIFE SCI HUMAN TECHNOL

Go to start page